Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26 TTM Selling/general/admin expenses 2.31 M8.52 M667 K1.85 M6.2 M 17.23 M Research & development ————— — Operating income 24.5 M22.51 M10.09 M32.49 M32.75 M 97.84 M Non-Operating Income, Total ————— — Interest expense, net of interest capitalized 7.94 M6.45 M4.34 M1.83 M440 K 13.06 M Non-Operating Income, excl. Interest Expenses ————— — Unusual income/expense ————— — Pretax income 16.57 M16.07 M5.75 M30.66 M34.15 M 86.62 M Equity in earnings ————— — Taxes 2.6 M2.43 M2.16 M8.36 M5.09 M 18.04 M Non-controlling/minority interest ————— — After tax other income/expense ————— — Net income before discontinued operations 13.97 M13.64 M3.59 M22.3 M29.05 M 68.58 M Discontinued operations -22.94 M-10.44 M321 K-8.73 M0 -18.85 M Net income -8.97 M3.2 M3.91 M13.57 M29.05 M 49.73 M Dilution adjustment ————— — Preferred dividends ————— — Diluted net income available to common stockholders -8.97 M3.2 M3.91 M13.57 M29.05 M 49.73 M Basic earnings per share (Basic EPS) -0.430.150.190.641.06 2.04 Diluted earnings per share (Diluted EPS) -0.440.160.190.641.04 2.03 Average basic shares outstanding 20.62 M20.67 M20.68 M21.14 M27.5 M — Diluted shares outstanding 20.74 M20.73 M20.76 M21.24 M27.83 M — EBITDA 32.11 M23.63 M19.61 M40.8 M39.29 M 123.34 M EBIT 22.18 M14 M9.42 M30.61 M26.54 M 80.57 M Cost of revenue ————— — Other cost of goods sold ————— — Depreciation & amortization (cash flow) 9.9 M9.63 M10.19 M10.19 M12.75 M 42.77 M